Drugs / Vinoresin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05075460 Background | Oct 2021 → May 2024 | T-cell non-Hodgkin lymphoma | Peking Union Medical College Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vinoresin | “Vinoresin (VDS) 4mg intravenous infusion, day 1;” NCT05075460 ↗ |
| Route | Intravenous | “Vinoresin (VDS) 4mg intravenous infusion, day 1;” NCT05075460 ↗ |